Cargando…
A single nucleotide polymorphism genotyping platform for the authentication of patient derived xenografts
Patient derived xenografts (PDXs) have become a vital, frequently used, component of anti-cancer drug development. PDXs can be serially passaged in vivo for years, and shared across laboratories. As a consequence, the potential for mis-identification and cross-contamination is possible, yet authenti...
Autores principales: | El-Hoss, Jad, Jing, Duohui, Evans, Kathryn, Toscan, Cara, Xie, Jinhan, Lee, Hyunjoo, Taylor, Renea A., Lawrence, Mitchell G., Risbridger, Gail P., MacKenzie, Karen L., Sutton, Rosemary, Lock, Richard B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312397/ https://www.ncbi.nlm.nih.gov/pubmed/27528024 http://dx.doi.org/10.18632/oncotarget.11125 |
Ejemplares similares
-
Reversal of glucocorticoid resistance in paediatric acute lymphoblastic leukaemia is dependent on restoring BIM expression
por: Toscan, Cara E., et al.
Publicado: (2020) -
To target or not to target the enemy within localized prostate cancer
por: Risbridger, Gail, et al.
Publicado: (2013) -
Obesity does not promote tumorigenesis of localized patient-derived prostate cancer xenografts
por: Lo, Jennifer C.Y., et al.
Publicado: (2016) -
PDX: Moving Beyond Drug Screening to Versatile Models for Research Discovery
por: Risbridger, Gail P, et al.
Publicado: (2020) -
SAT-330 Preclinical Screen of Patient CRPC Tumors Shows Sensitivity to Bromodomain Inhibitors Includes AR-null and Neuroendocrine Disease
por: Risbridger, Gail, et al.
Publicado: (2019)